Table 12 Decision matrix.

From: Quantitative structure property relationship and multiattribute decision analysis of antianginal drugs using topological indices

Alternatives

M\(_{1}\)(G)

M\(_{2}\)(G)

H(G)

F(G)

ISI(G)

AZI(G)

ABC(G)

HM(G)

GA(G)

Optimization direction

max

max

max

max

max

max

max

min

min

Weights

0.20

0.12

0.231

0.19

0.08

0.04

0.13

0.002

0.007

Optimal values

186

223

16.1857

496

43.8476

311.8975

26.9839

62

6.6547

Acebutolol

110

120

10.7333

276

25.3667

171.0313

17.5460

516

22.9167

Ranolazine

154

175

14.4667

384

36.5667

255.6719

23.6508

734

32.0634

Metoprolol

80

85

8.2667

192

18.7176

130.125

13.0561

362

17.3590

Amlodipine

136

160

12.9667

346

32.4

240.625

20.6201

666

28.1511

Atenolol

86

91

8.5

212

19.75

128.875

13.9820

394

18.1281

Carvedilol

154

180

14.5333

378

37.5167

276.3281

23.2417

738

32.5462

Nitroglycerin

62

62

6.4

154

13.7

84.25

10.5558

278

13.0749

Nadolol

112

126

9.6333

304

25.2833

163.4080

16.9471

556

21.7590

Amyl nitrite

28

26

3.5667

62

6.3667

46.75

5.1685

62

6.6547

Nicorandil

66

70

6.9333

156

15.55

109.5156

10.8943

296

14.5173

Propranolol

92

103

8.8667

226

21.85

152.9063

14.3894

432

19.4364

Molsidomine

82

92

8.1

198

19.7167

142.7656

12.7969

382

17.6270

Nicardipine

176

205

16.0333

452

41.5167

290.75

26.6052

862

35.7423

Nifedipine

126

151

11.2333

334

29.5333

210.7656

18.6772

636

24.9605

Diltiazem

148

173

13.3667

380

35.0167

245.2188

22.2246

726

30.0103

Ivabradine

186

223

16.1857

496

43.8476

311.8975

26.9839

942

36.7746